Bristol Myers Squibb's Presentations at ASH 2024 Reinforce ...

Corporate news details - Bristol Myers Squibb - Press Releases

Bristol Myers Squibb's Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research ...

PRINCETON, N.J., November 19, 2024--BMS' Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in ...

Bristol Myers Squibb's Presentations at ASH 2024 Reinforce ...

Bristol Myers Squibb's Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research ...

ASH 2024 preview – multiple myeloma in focus - Oncology Pipeline

But multiple myeloma treatment is about more than just BCMA, and ASH offers key updates also on Bristol Myers Squibb's Revlimid follow-on ...

Friday Satellite Symposia - Hematology.org

The MDSF ASH 2024 Symposium will focus on challenges the MDS community faces in 2024. ... Bristol Myers Squibb, and Geron. December 06, 2024 7:00 a.m. - 10:00 ...

ASH 2024 preview – CD19 back on the agenda - Oncology Pipeline

In Car-T therapy three companies – Novartis, Bristol Myers Squibb ... Selected oral presentations at ASH 2024 on CD19-directed therapies ...

Bristol Myers Squibb to Present Data at ASCO & EHA from More ...

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society ...

Browse By Disease - Hematology.org

ASH provides the opportunity to browse the annual meeting program by disease. Select a disease from the dropdown list below to view all sessions within that ...

How We Do ItÂ®: New Combinations Reshaping Treatment ...

; Bristol Myers Squibb/Celgene: Consultancy, Honoraria, Other: Research ... presentations. To further enhance the integration of recent data into ...

ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies

Expect to see major presentation of data across Bristol Myers Squibb (BMS)'s oncology and hematology portfolio including data from more than 130 company- ...

Pharmaceutical press releases & news - Bristol Myers Squibb

Explore Bristol Myers Squibb's latest press releases to learn more about our company, our medicines and research innovation, our partnerships, our people, ...

Annual Meeting Sessions on Diversity, Equity, and Inclusion

Bristol Myers Squibb Madison, NJ Industry Careers. Alisa S Wolberg, PhD ... The talks contain little to no slides and draw the entire audience of ASH-a ...

Supplemental Prospectus - Form 424B3 - Public now

Bristol-Myers Squibb Company · Bristol Myers Squibb's Presentations at ASH 2024 Reinforce Strength of[...] More. search. Cero Therapeutics ...

Q1 2024 Results - Bristol Myers Squibb

This presentation contains statements about Bristol-Myers Squibb Company's (the “Company”) future financial results, plans, ...

Ero Copper Files Technical Report for the Furnas Copper-Gold Project

Bristol-Myers Squibb Company · Bristol Myers Squibb's Presentations at ASH 2024 Reinforce Strength of[...] More. search. Ero Copper Corp. 11/19/ ...

Bristol Myers Squibb Presents New Data at ASH 2023 ... - BioSpace

... presentation selected as part of the 2024 Highlights of ASH for lymphoma. ... reinforces the significant progress that we are making toward ...

Q2 2024 Results - Bristol Myers Squibb

This presentation includes certain non-generally accepted accounting principles (“GAAP”) financial measures that we use to describe the ...

ASH Annual Meeting Abstracts - Hematology.org

Abstracts for the 2024 ASH Annual Meeting and Exposition are now available. ... Abstracts submitted for oral and poster presentation at the ASH annual ...

Century Therapeutics Announces Upcoming Poster Presentations at ...

Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting ... Pictured: Bristol ...

Bristol Myers: presents new data to ASH - MarketScreener

Bristol Myers Squibb has announced the presentation of more than 90 data disclosures, including 18 oral presentations, from its hematology ...